Bioeconomy
100 VCs and 1 fund investing in Bioeconomy
VCs investing in Bioeconomy
Dirk Kersten
Managing Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Dirk Kersten invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Geert-Jan Mulder
Managing Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Geert-Jan Mulder invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Sander Slootweg
Managing Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Sander Slootweg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Martien van Osch
Managing Partner & CFO
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Martien van Osch is listed in a Managing Partner & CFO capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Jon Edwards
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Jon Edwards invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Nanna Lüneborg
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Nanna Lüneborg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Marco Boorsma
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Marco Boorsma invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Jasper Bos
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Jasper Bos invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Joy Faucher
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Joy Faucher invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Alexander Hoffmann
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Alexander Hoffmann invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Dmitrij Hristodorov
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Dmitrij Hristodorov invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Wouter Joustra
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Wouter Joustra invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Rogier Rooswinkel
General Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Rogier Rooswinkel invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Robbert van de Griendt
General Partner IR & Impact
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Robbert van de Griendt is listed in a General Partner IR & Impact capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Machteld Groeneveld
Chief Legal Risk & Compliance Officer
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Machteld Groeneveld is listed in a Chief Legal Risk & Compliance Officer capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Wilfred Kevelam
Chief Accounting Officer
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Wilfred Kevelam is listed in a Chief Accounting Officer capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Regina Salvat
Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Regina Salvat invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Thijs Verburg
Partner, Investor Relations
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Thijs Verburg is listed in a Partner, Investor Relations capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Mathias Vinther
Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Mathias Vinther invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Audrey Cacaly
Principal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Audrey Cacaly invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Vanessa Carle
Principal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Vanessa Carle invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Morgan Haller
Principal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Morgan Haller invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Meike Logtenberg
Principal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Meike Logtenberg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Tim Lohoff
Principal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Tim Lohoff invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Carolin Lanfer
Senior Associate
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Carolin Lanfer invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Gilles van Tienderen
Senior Associate
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Gilles van Tienderen invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Melanie de Almeida
Senior Associate
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Melanie de Almeida invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Kanay Khakhria
Senior Associate
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Kanay Khakhria invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Maximilien Souvereyns
Associate
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Maximilien Souvereyns invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Luuk de Vries
Senior Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Luuk de Vries invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Roberto Hofmann
Senior Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Roberto Hofmann invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Joseph Iwasyk
Senior Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Joseph Iwasyk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Sarah Neshat
Senior Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Sarah Neshat invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Nat Kolber
Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Nat Kolber invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Charlotte Koldeweij
Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Charlotte Koldeweij invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Vincent Loon
Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Vincent Loon invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Vivien Veninga
Analyst
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Vivien Veninga invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
James Bayne
Fellow
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
James Bayne is listed in a Fellow capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Alice Evans
Fellow, BioEconomy
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Alice Evans is listed in a Fellow, BioEconomy capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Sebastien Garnier
Fellow, BioEconomy
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Sebastien Garnier is listed in a Fellow, BioEconomy capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Maja Wojtynska
Fellow
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Maja Wojtynska is listed in a Fellow capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Per Falholt
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Per Falholt is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Rory Gummerson
Operating Partner, Talent Acquisition
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Rory Gummerson is listed in a Operating Partner, Talent Acquisition capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Peter Høngaard Andersen
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Peter Høngaard Andersen is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Carlo Incerti
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Carlo Incerti is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
John J.P. Kastelein
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
John J.P. Kastelein is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Ton Logtenberg
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Ton Logtenberg is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
John McDonald
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
John McDonald is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
John Montana
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
John Montana is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Gijs van den Brink
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Gijs van den Brink is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Sander van Deventer
Operating Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Sander van Deventer is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Philip Astley-Sparke
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Philip Astley-Sparke invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Josh Brumm
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Josh Brumm invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Matt Cooper
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Matt Cooper invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Cees de Jong
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Cees de Jong invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Michael Hayden
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Michael Hayden invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Gökben Koca
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Gökben Koca invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Jonathan McNeill
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Jonathan McNeill invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Yigal M. Pinto
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Yigal M. Pinto invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Patrick Round
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Patrick Round invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Onno van de Stolpe
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Onno van de Stolpe invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Patrick Vink
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Patrick Vink invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Jens Wendland
Venture Partner
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Jens Wendland invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Michael Burgess
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Michael Burgess is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Simon J Clark
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Simon J Clark is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
John Ford
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
John Ford is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Scott Friedman
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Scott Friedman is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Frank G. Holz
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Frank G. Holz is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
An Michiels
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
An Michiels is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Stefan Oschmann
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Stefan Oschmann is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Holger Reithinger
Senior Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Holger Reithinger is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Steen Riisgaard
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Steen Riisgaard is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Liz Rodgers
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Liz Rodgers is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Floor Saris
Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Floor Saris is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Feike Sijbesma
Senior Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Feike Sijbesma is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Alice Vickers
Venture Advisor
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Alice Vickers is listed in a Venture Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Laura Asbjornsen
Head of Marketing & Communications
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Laura Asbjornsen is listed in a Head of Marketing & Communications capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Silva Dezelan
Head of Impact and ESG
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Silva Dezelan is listed in a Head of Impact and ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Jennifer Fritzsche
Vice President Finance
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Jennifer Fritzsche is listed in a Vice President Finance capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Cyril Lesser
Vice President Finance - Funds
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Cyril Lesser is listed in a Vice President Finance - Funds capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Arjan Oosterheert
Head of Tax
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Arjan Oosterheert is listed in a Head of Tax capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Marc van Voorst tot Voorst
Head of Public Affairs
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Marc van Voorst tot Voorst is listed in a Head of Public Affairs capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Joost de Rijk
Investor Relations Director
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Joost de Rijk is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Lior Alperovich
Marketing & Communications Director
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Lior Alperovich is listed in a Marketing & Communications Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Vincent Conijn
Senior Associate, Impact & ESG
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Vincent Conijn is listed in a Senior Associate, Impact & ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Bart de Jong
Finance Manager
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Bart de Jong is listed in a Finance Manager capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Baris Duvan
Senior Paralegal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Baris Duvan is listed in a Senior Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Marnix Groot
Fund Controller
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Marnix Groot is listed in a Fund Controller capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Stijn Jochemsen
Finance Director
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Stijn Jochemsen is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Francine MacLeod
HR Administrator
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Francine MacLeod invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Walter Schram
Finance Director
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Walter Schram is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Devan Sequeira
IT Solution Architect
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Devan Sequeira is listed in a IT Solution Architect capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Thijs van Egmond
Legal Counsel
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Thijs van Egmond is listed in a Legal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Pascal van Wees
Finance Director
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Pascal van Wees is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Iris Veldman
Deal Counsel
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Iris Veldman is listed in a Deal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Viktorija Vodilovska
AI Specialist
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Viktorija Vodilovska is listed in a AI Specialist capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Patricia Vonk
AML/KYC Manager
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Patricia Vonk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.
Maureen Wouters
Paralegal
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Maureen Wouters is listed in a Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Rachelle Young
Investor Relations Director
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Rachelle Young is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Danielle de Magalhães
Executive Assistant
Forbion
Check: Forbion does not publish one standard current check-size range across its funds on the official site.
Danielle de Magalhães invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.